---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-002490"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2026-03-19T23:59:59+00:00"
generated_at: "2026-05-15T09:43:37.126234+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# SynCardia TAH bridges patient for 119 days to successful heart transplant at UCSF Health

## Summary
- Male patient in his twenties with biventricular heart failure received SynCardia TAH on Nov 15, 2025.
- Device provided 119 days of circulatory support; successful heart transplant on March 14, 2026.
- Second of five patients at UCSF Health successfully bridged to transplant using SynCardia TAH.
- UCSF surgical director Amy Fiedler, MD, noted patient recovering well and praised partnership with SynCardia.
- CEO Patrick Schnegelsberg cited growing adoption at leading transplant centers.

## SEC filing metadata
- accession: 0001829126-26-002490
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2026-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000182912626002490/0001829126-26-002490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000182912626002490/picardmedical_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-002490
- JSON: https://secwatch.observer/filing/0001829126-26-002490.json
- Plain text: https://secwatch.observer/filing/0001829126-26-002490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.